Walter J. (Wally) Curran, Jr. said he would step down as executive director of Winship Cancer Institute of Emory University to serve as the global chief medical officer of GenesisCare, an international group described as “the world’s largest provider of radiation oncology care and a major global provider of other medical services.”
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
